In breast cancer, garcinol was shown to inhibit STAT3-NF-kB signaling, resulting in reduced invasiveness, in vitro, and significantly attenuated tumor growth in NOD-SCID mice [33,34]; thus, building a case for the preclinical investigation of the probable anti-GBM effect of garcinol in this stance. Here, STAT3 is linked to glioblastoma.